x NoneEntity Type
0001059784
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 GENEREX BIOTECHNOLOGY CORP
Jurisdiction of Incorporation/OrganizationDELAWARE 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 GENEREX BIOTECHNOLOGY CORP 
Street Address 1Street Address 2
 10102 USA TODAY WAY 
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 MIRAMAR FLORIDA 33025 416-364-2551 



3. Related Persons
Last NameFirst NameMiddle Name
MoscatoJoseph
Street Address 1Street Address 2
10102 USA Today Way
CityState/Province/CountryZIP/Postal Code
MiramarFLORIDA33025
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 CEO, President, and Chairman of the Board

Last NameFirst NameMiddle Name
RoAndrew
Street Address 1Street Address 2
10102 USA Today Way
CityState/Province/CountryZIP/Postal Code
MiramarFLORIDA33025
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 Chief Investment Officer and Director

Last NameFirst NameMiddle Name
CorraoMark
Street Address 1Street Address 2
10102 USA Today Way
CityState/Province/CountryZIP/Postal Code
MiramarFLORIDA33025
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 Chief Financial Officer and Treasurer

Last NameFirst NameMiddle Name
ThompsonTerry
Street Address 1Street Address 2
10102 USA Today Way
CityState/Province/CountryZIP/Postal Code
MiramarFLORIDA33025
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 Chief Operating Officer

 
Last NameFirst NameMiddle Name
CrisciAnthony
Street Address 1Street Address 2
10102 USA Today Way
CityState/Province/CountryZIP/Postal Code
MiramarFLORIDA33025
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 Chief Legal Officer

Last NameFirst NameMiddle Name
PurcellRichard
Street Address 1Street Address 2
10102 USA Today Way
CityState/Province/CountryZIP/Postal Code
MiramarFLORIDA33025
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 Executive Vice President of Research & Drug Development

Last NameFirst NameMiddle Name
TerrellJason
Street Address 1Street Address 2
10102 USA Today Way
CityState/Province/CountryZIP/Postal Code
MiramarFLORIDA33025
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 Chief Scientific Officer

Last NameFirst NameMiddle Name
EagleCraig
Street Address 1Street Address 2
10102 USA Today Way
CityState/Province/CountryZIP/Postal Code
MiramarFLORIDA33025
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 Independent Director

 
Last NameFirst NameMiddle Name
McGeeBrian
Street Address 1Street Address 2
10102 USA Today Way
CityState/Province/CountryZIP/Postal Code
MiramarFLORIDA33025
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 Independent Director

Last NameFirst NameMiddle Name
AndersonJames
Street Address 1Street Address 2
10102 USA Today Way
CityState/Province/CountryZIP/Postal Code
MiramarFLORIDA33025
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 Independent Director

Last NameFirst NameMiddle Name
SalvoLawrence
Street Address 1Street Address 2
10102 USA Today Way
CityState/Province/CountryZIP/Postal Code
MiramarFLORIDA33025
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 Independent Director

Last NameFirst NameMiddle Name
PriolettiMark
Street Address 1Street Address 2
10102 USA Today Way
CityState/Province/CountryZIP/Postal Code
MiramarFLORIDA33025
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 Independent Director

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  x Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance o Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2020-08-04 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities x Option, Warrant or Other Right to Acquire Another Security
x Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
  


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
 Dawson James Securities, Inc 130645
(Associated) Broker or Dealer x None(Associated) Broker or Dealer CRD Number x None
    
Street Address 1Street Address 2
 1 N. Federal Highway 5th Floor  
City State/Province/CountryZIP/Postal Code
 Boca Raton FLORIDA 33432
State(s) of Solicitation o All States o Foreign/Non-US
 FLORIDA
 NEW YORK
 

 



13. Offering and Sales Amounts
Total Offering Amount $   USD x Indefinite
Total Amount Sold $ 2000000 USD 
Total Remaining to be Sold $   USD x Indefinite
 
Clarification of Response (if Necessary)
 Common shares of the company's common stock and warrants were issued in a private placement, as disclosed on the issuer's Current Report on Form 8-K, filed with the SEC on August 7, 2020.


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 3


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 80000 USD o Estimate
Finders' Fees$ 0 USD o Estimate
 
Clarification of Response (if Necessary)
 Represents a Placement Agent Fee payable to Dawson James Securities, Inc.


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD o
Generex Biotechnology (CE) (USOTC:GNBT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Generex Biotechnology (CE) Charts.
Generex Biotechnology (CE) (USOTC:GNBT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Generex Biotechnology (CE) Charts.
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No GNBT Message Board. Create One! See More Posts on GNBT Message Board See More Message Board Posts

Generex Biotechnology Corp News

Loading Messages....

More Generex Biotechnology Corp News Articles